Nicholas (Nick) Ecos is CEO of Arcis Biotechnology, a developer of chemistry-based tools that simplify preparation of samples for molecular analysis. He was previously CEO of Biomatrica where he led the development of biomarker collection products and the subsequent sale of the company to Exact Sciences Corporation. He previously spent over 20 years with Life Technologies (now Thermo Fisher Scientific) as Vice President and General Manager of several global business units supplying pharma and diagnostics companies with instrument and reagent components for their gene and cell therapies and diagnostic systems. One such unit, in Oslo, Norway, provided reagents used in Kymriah®, the first FDA-cleared CAR-T cell therapy. Other roles included Vice President of Sales, Americas of Upstate Biotechnology (now Millipore Sigma) and, before that, General Manager, Latin America of Invitrogen (now Thermo Fisher Scientific). He holds an MBA from Harvard Business School and a B.S. from Ohio State University. Mr. Ecos joined the Board in 2020.